Explore more publications!
Vanuatu Health Times
Got News to Share?

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 17, 2025

Immatics Announces Third Quarter 2025 Financial Results and Business Update
November 17, 2025

Immatics Announces Third Quarter 2025 Financial Results and Business Update

Indeterminate GlobeNewswire
Fortrea Appoints Agnieszka Gallagher as General Counsel
November 17, 2025

Fortrea Appoints Agnieszka Gallagher as General Counsel

Indeterminate GlobeNewswire
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
November 17, 2025

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

Indeterminate GlobeNewswire
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
November 17, 2025

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment
November 17, 2025

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

Indeterminate GlobeNewswire
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
November 17, 2025

Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

Indeterminate GlobeNewswire
Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy
November 17, 2025

Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy

Indeterminate GlobeNewswire
Validic Joins Digital Medicine Society Initiative to Advance Connected Health for Older Adults
November 17, 2025

Validic Joins Digital Medicine Society Initiative to Advance Connected Health for Older Adults

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
November 17, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
J-Star Announces General Meeting of Shareholders
November 17, 2025

J-Star Announces General Meeting of Shareholders

Indeterminate GlobeNewswire
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
November 17, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

Indeterminate GlobeNewswire
4DMT Appoints Kristian Humer as Chief Financial Officer
November 17, 2025

4DMT Appoints Kristian Humer as Chief Financial Officer

Indeterminate GlobeNewswire
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
November 17, 2025

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Indeterminate GlobeNewswire
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
November 17, 2025

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Indeterminate GlobeNewswire
High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
November 17, 2025

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Indeterminate GlobeNewswire
Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse
November 17, 2025

Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse

Indeterminate GlobeNewswire
Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”
November 17, 2025

Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”

Indeterminate GlobeNewswire
ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma
November 17, 2025

ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma

Indeterminate GlobeNewswire
Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health
November 17, 2025

Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health

Indeterminate GlobeNewswire
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
November 17, 2025

Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions